Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical lipidomics – A community-driven roadmap to translate research into clinical applications
Olga Vvedenskaya, Michal Holčapek, Michael Vogeser, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2022) Vol. 24, pp. 1-4
Open Access | Times Cited: 23

Showing 23 citing articles:

Omic-Scale High-Throughput Quantitative LC–MS/MS Approach for Circulatory Lipid Phenotyping in Clinical Research
Jéssica Medina, Rébecca Borreggine, Tony Teav, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 6, pp. 3168-3179
Open Access | Times Cited: 25
Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts
Habtamu B. Beyene, Corey Giles, Kevin Huynh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Comprehensive Lipidomic Workflow for Multicohort Population Phenotyping Using Stable Isotope Dilution Targeted Liquid Chromatography-Mass Spectrometry
Monique Ryan, Alanah Grant-St James, Nathan G. Lawler, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 5, pp. 1419-1433
Open Access | Times Cited: 23
Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review
Ekaterina Demicheva, Vladislav Dordiuk, Fernando Polanco Espino, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 54-54
Open Access | Times Cited: 9
Metabolomics and lipidomics strategies in modern drug discovery and development
Giuseppe Astarita, Rachel S. Kelly, Jessica Lasky‐Su
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103751-103751
Open Access | Times Cited: 18
Clinical lipidomics in the era of the big data
Aleš Kvasnička, Lukáš Najdekr, Dana Dobešová, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 4, pp. 587-598
Open Access | Times Cited: 17
Lipidomics—Paving the Road towards Better Insight and Precision Medicine in Rare Metabolic Diseases
Martina Zandl‐Lang, Barbara Plecko, Harald Köfeler
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1709-1709
Open Access | Times Cited: 11
NAFPD exacerbation by hyperlipidemia combined with hyperuricemia: a pilot rat experiment in lipidomics
Jingyun Li, Yongjian Chen, Shilin Li, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access
Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation
Sebastian Bass-Stringer, Bianca C. Bernardo, Gunes S. Yildiz, et al.
Journal of sport and health science/Journal of Sport and Health Science (2025), pp. 101023-101023
Open Access
Microbiota–Gut–Brain Axis: Mass-Spectrometry-Based Metabolomics in the Study of Microbiome Mediators—Stress Relationship
Nicolò Interino, Rosalba Vitagliano, Federica D’Amico, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 243-243
Open Access
Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study
Habtamu B. Beyene, Kevin Huynh, Tingting Wang, et al.
EBioMedicine (2024) Vol. 105, pp. 105187-105187
Open Access | Times Cited: 3
Effects of Different Storage Conditions on Lipid Stability in Mice Tissue Homogenates
Erika Dorochow, Robert Gurke, Samuel Rischke, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 504-504
Open Access | Times Cited: 8
Ex vivo instability of lipids in whole blood: preanalytical recommendations for clinical lipidomics studies
Qingqing Wang, Miriam Hoene, Chunxiu Hu, et al.
Journal of Lipid Research (2023) Vol. 64, Iss. 6, pp. 100378-100378
Open Access | Times Cited: 8
Advancements in Mass Spectrometry-Based Targeted Metabolomics and Lipidomics: Implications for Clinical Research
Nguyen Ky Anh, Nguyen Quang Thu, Nguyen Tran Nam Tien, et al.
Molecules (2024) Vol. 29, Iss. 24, pp. 5934-5934
Open Access | Times Cited: 2
From research cohorts to the patient – a role for “omics” in diagnostics and laboratory medicine?
Michael Vogeser, Anne K. Bendt
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 6, pp. 974-980
Open Access | Times Cited: 6
Prioritize biologically relevant ions for data-independent acquisition (BRI-DIA) in LC–MS/MS-based lipidomics analysis
Likun Duan, Grace Scheidemantle, Mareca Lodge, et al.
Metabolomics (2022) Vol. 18, Iss. 8
Closed Access | Times Cited: 9
Recent advances, challenges, and future directions in the mass spectrometry analysis of glycosphingolipids in biological samples
Karel Hořejší, Denisa Kolářová, Robert Jirásko, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117827-117827
Open Access | Times Cited: 1
Factors affecting variability in free oxylipins in mammalian tissues
Harold M. Aukema, Amir Ravandi
Current Opinion in Clinical Nutrition & Metabolic Care (2022)
Closed Access | Times Cited: 6
Mass Sportrometry: An annual look back at applications of mass spectrometry in sport and exercise science
Marilyn Li Yin Ong, Christopher G. Green, Samantha N. Rowland, et al.
Analytical Science Advances (2023) Vol. 4, Iss. 3-4, pp. 60-80
Open Access | Times Cited: 2
‘Omic-scale quantitative HILIC-MS/MS approach for circulatory lipid phenotyping in clinical research
Jéssica Medina, Rébecca Borreggine, Tony Teav, et al.
(2022)
Open Access | Times Cited: 2
Prioritize biologically relevant ions for data-independent acquisition (BRI- DIA) in LC-MS/MS-based lipidomics analysis
Likun Duan, Grace Scheidemantle, Mareca Lodge, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 1
Lipids regulated by exercise and phosphoinositide 3-kinase: potential role as biomarkers and therapeutic targets for cardiovascular disease
T. Belkin, Yow Keat Tham, Julie R. McMullen
Current Opinion in Physiology (2023) Vol. 32, pp. 100633-100633
Closed Access
Lipidomics in Clinical Diagnostics
Jayashree Selvalatchmanan, Markus R. Wenk, Anne K. Bendt
(2023), pp. 557-584
Closed Access
Page 1

Scroll to top